Inherited disorders affecting dopamine and serotonin: Critical neurotransmitters derived from aromatic amino acids

Journal of Nutrition

Volumn 137, Issue 6, 2007, Pages

  Hyland, Keith ^a  

^a Horizon Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AROMATIC AMINO ACID; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LAXATIVE; MONOAMINE OXIDASE INHIBITOR; NEUROTRANSMITTER; PERGOLIDE; PHENYLALANINE 4 MONOOXYGENASE; PRAMIPEXOLE; SELEGILINE; SEPIAPTERIN REDUCTASE; SEROTONIN; TETRAHYDROBIOPTERIN; TRANYLCYPRAMINE; TRIHEXYPHENIDYL; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DYSKINESIA; ENZYME DEFICIENCY; GENETIC DISORDER; HETEROZYGOTE; HUMAN; HYPERPHENYLALANINEMIA; IRRITABILITY; METABOLISM; PHENOTYPE; PHENYLKETONURIA; SIDE EFFECT; SYMPTOM; SYNTHESIS;

EID: 34249823680     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.6.1568s     Document Type: Conference Paper

References (37)

1. Folling A. Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoffwechselanormalie in Verbindung mit Imbezillitat. Hoppe Seylers Z Physiol Chem. 1934;169-76.
2. Niederwieser A, Blau N, Wang M, Joller P, Atares M, Cardesa-Garcia J. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr. 1984;141:208-14.
3. Niederwieser A, Leimbacher W, Curtius HC, Ponzone A, Rey F, Leupold D. Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: absence of phosphate-eliminating enzyme activity demonstrated in liver. Eur J Pediatr. 1985;144:13-6.
4. Blau N, Dhondt JL, Guibaud P, Kuster T, Curtius HC. New variant of hyperphenylalaninaemia with excretion of 7-substituted pterins. Eur J Pediatr. 1988;148:176.
5. Kaufman S, Holtzman NA, Milstien S, Butler LJ, Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975;293:785-90.
6. Blau N, Thony B, Cotton RG, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 1725-76.
7. Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab. 2001;74:172-85.
8. Bonafe L, Thony B, Penzien JM, Czarnecki B, Blau N. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet. 2001;69:269-77.
9. Hyland K. Neurochemistry and defects of biogenic amine neurotransmitter metabolism. J Inherit Metab Dis. 1999;22:353-63.
10. Nygaard TG, Snow BJ, Fahn S, Calne DB. Dopa-responsive dystonia: clinical characteristics and definitions. In: Segawa M, editor. Hereditary progressive dystonia with marked diurnal fluctuation. Lancaster (UK): Parthenon; 1993. p. 3-13.
11. Van Hove JL, Steyaert J, Matthijs G, Legius E, Theys P, Wevers R, Romstad A, Moller LB, Hedrich K, et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry. 2006;77:18-23.
12. Furukawa Y, Kish SJ, Bebin EM, Jacobson RD, Fryburg JS, Wilson WG, Shimadzu M, Hyland K, Trugman JM. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol. 1998;44:10-6.
13. Kaufman S. Some metabolic relationships between biopterin and folate: implications for the "methyl trap hypothesis". Neurochem Res. 1991;16:1031-6.
14. Blau N, Bonafe L, Blaskovics M. Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N, Duran M, Blaskovics M, Gibson KM, editors. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. Berlin: Springer; 2002. p. 91-106.
15. Hoffmann GF, Assmann B, Brautigam C, Dionisi-Vici C, Haussler M, de Klerk JB, Naumann M, Steenbergen-Spanjers GC, Strassburg HM, et al. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol. 2003;54 Suppl 6:S56-65.
16. Swoboda KJ, Saul JP, McKenna CE, Speller NB, Hyland K. Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes. Ann Neurol. 2003;54 Suppl 6:S49-55.
17. Abeling NG, van Gennip AH, Barth PG, van Cruchten A, Westra M, Wijburg FA. Aromatic L-amino acid decarboxylase deficiency: a new case with a mild clinical presentation and unexpected laboratory findings. J Inherit Metab Dis. 1998;21:240-2.
18. Burlina AB, Burlina AP, Hyland K, Bonafe L, Blau N. Autistic syndrome and aromatic L-amino acid decarboxylase (AADC) deficiency. J Inherit Metab Dis. 2001;24 Suppl 1:34.
19. Mills PB, Surtees RA, Champion MP, Beesley CE, Dalton N, Scambler PJ, Heales SJ, Briddon A, Scheimberg I, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet. 2005;14:1077-86.
20. Clayton PT, Surtees RA, DeVile C, Hyland K, Heales SJ. Neonatal epileptic encephalopathy. Lancet. 2003;361:1614.
21. Pons R, Ford B, Chiriboga CA, Clayton PT, Hinton V, Hyland K, Sharma R, De Vivo DC. Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology. 2004;62:1058-65.
22. Chang YT, Sharma R, Marsh JL, McPherson JD, Bedell JA, Knust A, Brautigam C, Hoffmann GF, Hyland K. Levodopa-responsive aromatic L-amino acid decarboxylase deficiency. Ann Neurol. 2004;55:435-8.
23. Brautigam C, Wevers RA, Hyland K, Sharma RK, Knust A, Hoffman GF. The influence of L-dopa on methylation capacity in aromatic L-amino acid decarboxylase deficiency: biochemical findings in two patients. J Inherit Metab Dis. 2000;23:321-4.
24. Hyland K. Abnormalities of biogenic amine metabolism. J Inherit Metab Dis. 1993;16:676-90.
25. Ponzone A, Guardamagna O, Spada M, Ferraris S, Ponzone R, Kierat L, Blau N. Differential diagnosis of hyperphenylalaninaemia by a combined phenylalanine-tetrahydrobiopterin loading test. Eur J Pediatr. 1993;152:655-61.
26. Niederwieser A, Ponzone A, Curtius HC. Differential diagnosis of tetrahydrobiopterin deficiency. J Inherit Metab Dis. 1985;8 Suppl 1:34-8.
27. Niederwieser A, Curtius HC, Bettoni O, Bieri J, Schircks B, Viscontini M, Schaub J. Atypical phenylketonuria caused by 7, 8-dihydrobiopterin synthetase deficiency. Lancet. 1979;1:131-3.
28. Curtius HC, Kuster T, Matasovic A, Blau N, Dhondt JL. Primapterin, anapterin, and 6-oxo-primapterin, three new 7-substituted pterins identified in a patient with hyperphenylalaninemia. Biochem Biophys Res Commun. 1988;153:715-21.
29. Trefz FK, Scheible D, Frauendienst-Egger G, Korall H, Blau N. Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin. Mol Genet Metab. 2005;86 Suppl 1:S75-80.
30. Hyland K, Fryburg JS, Wilson WG, Bebin EM, Arnold LA, Gunasekera RS, Jacobson RD, Rost-Ruffner E, Trugman JM. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology. 1997;48:1290-7.
31. Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N. Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem. 2001;47:477-85.
32. Van Der Heyden JC, Rotteveel JJ, Wevers RA. Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism. Eur J Paediatr Neurol. 2003;7:31-7.
33. Hyland K, Surtees RA, Rodeck C, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology. 1992;42:1980-8.
34. Jervis GA. Phenylpyruvic oligophrenia deficiency of phenylalanine- oxidizing system. Proc Soc Exp Biol Med. 1953;82:514-5.
35. Smith I, Lloyd J. Proceedings: atypical phenylketonuria accompanied by a severe progressive neurological illness unresponsive to dietary treatment. Arch Dis Child. 1974;49:245.
36. Hyland K, Clayton PT. Aromatic amino acid decarboxylase deficiency in twins. J Inherit Metab Dis. 1990;13:301-4.
37. Ludecke B, Knappskog PM, Clayton PT, Surtees RA, Clelland JD, Heales SJ, Brand MP, Bartholome K, Flatmark T. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet. 1996;5:1023-8.